Application of the PredictAD Software Tool to Predict Progression in Patients with Mild Cognitive Impairment-Reference-Cited by-同舟云学术

Application of the PredictAD Software Tool to Predict Progression in Patients with Mild Cognitive Impairment

Published:2012 Issue:5-6 Volume:34 Page:344-350
ISSN:1420-8008
Container-title:Dementia and Geriatric Cognitive Disorders
language:en
Short-container-title:Dement Geriatr Cogn Disord

Author:

Simonsen Anja H.,Mattila Jussi,Hejl Anne-Mette,Frederiksen Kristian S.,Herukka Sanna-Kaisa,Hallikainen Merja,van Gils Mark,Lötjönen Jyrki,Soininen Hilkka,Waldemar Gunhild

Publisher

S. Karger AG

Subject

Psychiatry and Mental health,Cognitive Neuroscience,Geriatrics and Gerontology

Reference14 articles.

1. Mild Cognitive Impairment

2. What is mild cognitive impairment? Variations in definitions and evolution of nondemented persons with cognitive impairment

3. Mild Cognitive Impairment: An Overview

4. Comparing predictors of conversion and decline in mild cognitive impairment

5. Neuropsychological Predictors of Dementia in a Three-Year Follow-Up Period: Data from the LADIS Study

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study;Alzheimer's Research & Therapy;2019-03-20

2. Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study;Current Alzheimer Research;2019-02-04

3. Development of a Late-Life Dementia Prediction Index with Supervised Machine Learning in the Population-Based CAIDE Study;Journal of Alzheimer's Disease;2016-12-06

4. Using the Disease State Fingerprint Tool for Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease;Dementia and Geriatric Cognitive Disorders Extra;2016-07-22

5. Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers;J ALZHEIMERS DIS;2016